Loreto Carmona

43.9k total citations · 5 hit papers
370 papers, 14.0k citations indexed

About

Loreto Carmona is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Loreto Carmona has authored 370 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Rheumatology, 79 papers in Hematology and 57 papers in Immunology. Recurrent topics in Loreto Carmona's work include Rheumatoid Arthritis Research and Therapies (165 papers), Autoimmune and Inflammatory Disorders Research (76 papers) and Spondyloarthritis Studies and Treatments (65 papers). Loreto Carmona is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (165 papers), Autoimmune and Inflammatory Disorders Research (76 papers) and Spondyloarthritis Studies and Treatments (65 papers). Loreto Carmona collaborates with scholars based in Spain, United Kingdom and United States. Loreto Carmona's co-authors include Juan J. Gómez‐Reino, M.Á. Descalzo, Emilio Martín Mola, Estíbaliz Loza, Vicente Rodríguez Valverde, Eva Salgado, Juan Ángel Jover, José Ramón Maneiro, Lydia Abásolo and Isidoro González‐Álvaro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Loreto Carmona

343 papers receiving 13.6k citations

Hit Papers

The global burden of rheu... 2001 2026 2009 2017 2014 2003 2001 2018 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
    2014 839 citations Loreto Carmona, Anthony D. Woolf et al. Annals of the Rheumatic Diseases profile →
  2. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance report
    2003 784 citations Loreto Carmona et al. profile →
  3. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey
    2001 500 citations Loreto Carmona et al. Annals of the Rheumatic Diseases profile →
  4. 2018 update of the EULAR recommendations for the management of hand osteoarthritis
    2018 308 citations Féline P B Kroon, Michael Doherty et al. Annals of the Rheumatic Diseases profile →
  5. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
    2021 171 citations Elena Nikiphorou, Andréa Marques et al. Annals of the Rheumatic Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Loreto Carmona 7.3k 2.6k 2.5k 2.5k 1.7k 370 14.0k
Mark Lunt 7.0k 0.9× 3.4k 1.3× 2.6k 1.0× 2.5k 1.0× 1.6k 0.9× 353 15.9k
Kaleb Michaud 8.5k 1.2× 2.0k 0.8× 3.0k 1.2× 1.1k 0.4× 1.5k 0.9× 266 13.7k
Laure Gossec 10.0k 1.4× 3.7k 1.5× 4.1k 1.6× 1.9k 0.8× 814 0.5× 529 14.8k
Jeffrey R. Curtis 11.3k 1.5× 4.0k 1.6× 4.1k 1.6× 4.4k 1.8× 3.7k 2.2× 684 25.1k
Clifton O. Bingham 4.7k 0.6× 1.9k 0.8× 1.6k 0.6× 1.1k 0.5× 912 0.5× 275 11.4k
Ted R. Mikuls 8.1k 1.1× 2.4k 0.9× 1.7k 0.7× 1.7k 0.7× 1.7k 1.0× 367 14.7k
Michael M. Ward 8.5k 1.2× 4.1k 1.6× 2.0k 0.8× 1.9k 0.8× 1.2k 0.7× 290 14.2k
Sherine E. Gabriel 16.4k 2.2× 4.1k 1.6× 3.2k 1.3× 5.3k 2.1× 2.6k 1.6× 202 29.3k
Kenneth G. Saag 7.4k 1.0× 1.8k 0.7× 2.5k 1.0× 6.0k 2.4× 2.7k 1.6× 476 26.7k
Cynthia S. Crowson 13.7k 1.9× 4.3k 1.7× 2.7k 1.1× 4.7k 1.9× 3.4k 2.0× 476 28.1k

Countries citing papers authored by Loreto Carmona

Since Specialization
Citations

This map shows the geographic impact of Loreto Carmona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loreto Carmona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loreto Carmona more than expected).

Fields of papers citing papers by Loreto Carmona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loreto Carmona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loreto Carmona. The network helps show where Loreto Carmona may publish in the future.

Co-authorship network of co-authors of Loreto Carmona

This figure shows the co-authorship network connecting the top 25 collaborators of Loreto Carmona. A scholar is included among the top collaborators of Loreto Carmona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loreto Carmona. Loreto Carmona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agache, Ioana, Marı́a José Torres, Ibon Eguíluz‐Gracia, et al.. (2025). Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry. Allergy. 80(6). 1677–1701. 1 indexed citations
2.
3.
Benavent, Diego, Loreto Carmona, María Montoro, et al.. (2024). Empowering rheumatology through digital health technologies: contributions and barriers. SHILAP Revista de lepidopterología. 2(2). 92–105. 2 indexed citations
4.
Otón, Teresa, et al.. (2024). The patient journey of fibromyalgia in Latin America. Reumatología Clínica (English Edition). 20(1). 32–42. 3 indexed citations
5.
Ferreira, Ricardo J O, Maria Adriana Henriques, Rikke Helene Moe, et al.. (2024). Presentation of the first international research network to foster high-quality clinical trials testing non-pharmacological interventions (TRACTION network). BMJ Open. 14(7). e081864–e081864. 1 indexed citations
6.
Castrejón, Isabel, Blanca Hernández‐Cruz, Rosario García‐Vicuña, et al.. (2023). Sesgos de género en la reumatología española: Percepciones y realidad. Reumatología Clínica. 19(7). 392–401.
7.
Otón, Teresa, et al.. (2023). El viaje del paciente con fibromialgia en Latinoamérica. Reumatología Clínica. 20(1). 32–42.
8.
Berti, Alvise, Gonçalo Boleto, Peter A. Merkel, et al.. (2022). Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review. Lara D. Veeken. 61(12). 4603–4618. 9 indexed citations
9.
Boleto, Gonçalo, Alvise Berti, Peter A. Merkel, et al.. (2022). Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review. The Journal of Rheumatology. 50(6). 789–798. 4 indexed citations
10.
Piskin, David, Micol Romano, Daniel Aletaha, et al.. (2022). Developing guidelines for ultrarare rheumatic disorders: a bumpy ride. Annals of the Rheumatic Diseases. 81(9). 1203–1205. 4 indexed citations
11.
Loza, Estíbaliz, Loreto Carmona, Anthony D. Woolf, et al.. (2022). Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake. Annals of the Rheumatic Diseases. 81(10). 1344–1347. 7 indexed citations
12.
Garrido‐Cumbrera, Marco, Helena Marzo‐Ortega, Laurent Grange, et al.. (2021). Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1). RMD Open. 7(1). e001546–e001546. 44 indexed citations
13.
Rodriguez-García, S. C., Raúl Castellanos‐Moreira, Jacqueline Usón, et al.. (2021). Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews. RMD Open. 7(2). e001658–e001658. 15 indexed citations
14.
Lawson‐Tovey, Saskia, Anja Strangfeld, Kimme L Hyrich, et al.. (2021). EULAR COVID-19 registry: lessons learnt and future considerations. Annals of the Rheumatic Diseases. 80(9). 1110–1115. 4 indexed citations
15.
Ritschl, Valentin, Tanja Stamm, Daniel Aletaha, et al.. (2020). 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Annals of the Rheumatic Diseases. 80(6). 707–713. 34 indexed citations
16.
Landewé, Robert, Pedro Machado, Féline P B Kroon, et al.. (2020). EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Annals of the Rheumatic Diseases. 79(7). 851–858. 153 indexed citations
17.
18.
Pablos, José L., María Galindo-Izquierdo, Loreto Carmona, et al.. (2020). Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Annals of the Rheumatic Diseases. 79(12). 1544–1549. 137 indexed citations
19.
20.
Almodóvar, Raquel, Loreto Carmona, Ana Urruticoechea‐Arana, et al.. (2018). The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study. Rheumatology International. 38(7). 1277–1284. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Lunt Breakdown of academic impact, for papers by Kaleb Michaud Breakdown of academic impact, for papers by Laure Gossec Breakdown of academic impact, for papers by Jeffrey R. Curtis Breakdown of academic impact, for papers by Clifton O. Bingham Breakdown of academic impact, for papers by Ted R. Mikuls Breakdown of academic impact, for papers by Michael M. Ward Breakdown of academic impact, for papers by Sherine E. Gabriel Breakdown of academic impact, for papers by Kenneth G. Saag Breakdown of academic impact, for papers by Cynthia S. Crowson
Rankless by CCL
2026